Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cocrystal Pharma Inc COCP

Healthcare
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function... see more

Recent & Breaking News (NDAQ:COCP)

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against LogMeIn, Inc. (LOGM) and Lead Plaintiff Deadline – October 19, 2018

GlobeNewswire October 3, 2018

COCRYSTAL LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Cocrystal Pharma, Inc. To Contact The Firm

PR Newswire October 2, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP

PR Newswire October 2, 2018

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PVG USAT MCHP COCP ABBV and ALNY

GlobeNewswire September 30, 2018

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Cocrystal Pharma, Inc. Investors (COCP)

Business Wire September 28, 2018

SHAREHOLDER ALERT: AMPE LCI CBS PM SKX PVG OPK USAT TRCO COCP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire September 28, 2018

COCP NOTICE: Rosen Law Firm Reminds Investors of Cocrystal Pharma, Inc. of Upcoming Deadline in Class Action – COCP (formerly known as BioZone Pharmaceuticals, Inc. - BZNE)

Business Wire September 28, 2018

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of PPDAI Group Inc. Investors (PPDF)

Business Wire September 28, 2018

COCRYSTAL PHARMA, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Cocrystal Pharma, Inc. (f/k/a/ BioZ

GlobeNewswire September 27, 2018

CLASS ACTION UPDATE for SKX and COCP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire September 27, 2018

SHAREHOLDER ALERT: NVRO PZZA NLSN ZN HMNY GDS PVG OPK USAT MCHP COCP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire September 26, 2018

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Skechers USA, Inc. (SKX) and Lead Plaintiff Deadline – November 5, 2018

GlobeNewswire September 26, 2018

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against OPKO Health, Microchip Technology, and Cocrystal and Encourages Investors to Contact the Firm

GlobeNewswire September 25, 2018

Robbins Arroyo LLP: The Controlling Shareholders of Cocrystal Pharma, Inc. (COCP) Engaged in Fraudulent Stock Scheme According to Recently Filed Class Action

Business Wire September 25, 2018

Scott+Scott Attorneys at Law LLP Alerts Investors to the Filing of Securities Class Action Against Cocrystal Pharma, Inc., formerly known as BioZone Pharmaceuticals, Inc. (COCP)

PR Newswire September 25, 2018

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against OPKO Health, Microchip Technology, and Cocrystal and Encourages Investors to Contact the Firm

GlobeNewswire September 24, 2018

COCRYSTAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Cocrystal Pharma, Inc. To Contact The Firm

Business Wire September 24, 2018

CLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In AbbVie Inc. (NYSE: ABBV) To Contact Brower Piven Before The Lead Plaintiff Deadline

GlobeNewswire September 24, 2018

INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire September 24, 2018

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TRCO, COCP and ABBV

GlobeNewswire September 23, 2018